Clindamycin
Product Images NDC 17478-120

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Clindamycin (NDC 17478-120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cli0c 0011 01

Chemical structure diagram of the active ingredient Clindamycin, showing its molecular arrangement including rings, functional groups, and chemical bonds.*

FDA Label Image

Cli0c 0011 02

Label for Clindamycin in 5% Dextrose Injection, 300 mg/50 mL, sterile and nonpyrogenic. The injectable solution is for intravenous use in a 50 mL single dose bottle, manufactured by Akorn, Inc. The label includes storage instructions, inactive ingredients, and cautions regarding use and clarity checks.*

FDA Label Image

Cli0c 0011 03

Clindamycin in 5% Dextrose Injection 300 mg/50 mL single dose bottle label. The product is for intravenous use and is manufactured by Akorn, Inc. The label includes storage instructions, dosage guidance, and a list of active and inactive ingredients. The packaging shows a 50 mL bottle size and warns against adding supplementary medication or use in series connections.*

FDA Label Image

Cli0c 0011 04

Label for Clindamycin in 5% Dextrose Injection, 600 mg/50 mL, sterile and nonpyrogenic intravenous injection. The 50 mL single-dose bottle is labeled for intravenous use only and is manufactured by Akorn, Inc. The label includes storage instructions, active and inactive ingredients, usage cautions, and barcode.*

FDA Label Image

Cli0c 0011 05

Clindamycin in 5% Dextrose Injection 600 mg/50 mL single dose bottle label by Akorn. Packaging indicates intravenous use, sterile and nonpyrogenic. Contains 50 mL per bottle with NDC 17478-121-50. Label includes active ingredient Clindamycin Phosphate equivalent to 600 mg Clindamycin and inactives including Dextrose Hydrous. Storage instructions and cautions about use and solution clarity are also visible.*

FDA Label Image

Cli0c 0011 06

Clindamycin in 5% Dextrose Injection 900 mg/50 mL single-dose bottle label by Akorn. The label includes active ingredient Clindamycin Phosphate equivalent to 900 mg Clindamycin, inactive ingredients, usage directions noting it is for intravenous use and not for rapid injection or IV push. Storage instructions specify 20° to 25°C and cautions against adding supplementary medication or using in series connections. The label states it is sterile, nonpyrogenic, and includes lot and expiration date fields.*

FDA Label Image

Cli0c 0011 07

Packaging label for Clindamycin in 5% Dextrose Injection, 900 mg/50 mL, single dose bottle by Akorn. The label includes usage instructions for intravenous use, storage conditions, active and inactive ingredients, and cautions. The label displays the NDC 17478-122-50 and features barcode and manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.